These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27004714)

  • 1. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.
    Scherrer JF; Salas J; Bucholz KK; Schneider FD; Burroughs T; Copeland LA; Sullivan MD; Lustman PJ
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):560-8. PubMed ID: 27004714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of hydrocodone vs. oxycodone in primary care.
    Harris RA; Kranzler HR; Chang KM; Doubeni CA; Gross R
    Drug Alcohol Depend; 2019 Dec; 205():107524. PubMed ID: 31707268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
    Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
    Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.
    Scherrer JF; Salas J; Copeland LA; Stock EM; Ahmedani BK; Sullivan MD; Burroughs T; Schneider FD; Bucholz KK; Lustman PJ
    Ann Fam Med; 2016; 14(1):54-62. PubMed ID: 26755784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
    Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
    Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of prescription opioid use duration and dose on development of treatment resistant depression.
    Scherrer JF; Salas J; Sullivan MD; Schneider FD; Bucholz KK; Burroughs T; Copeland L; Ahmedani B; Lustman PJ
    Prev Med; 2016 Oct; 91():110-116. PubMed ID: 27497660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
    Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
    JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013.
    Brooks JM; Petersen C; Kelly SM; Reid MC
    Int J Geriatr Psychiatry; 2019 Oct; 34(10):1481-1489. PubMed ID: 31134673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients.
    Scherrer JF; Salas J; Copeland LA; Stock EM; Schneider FD; Sullivan M; Bucholz KK; Burroughs T; Lustman PJ
    J Pain; 2016 Apr; 17(4):473-82. PubMed ID: 26884282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.
    Palangio M; Damask MJ; Morris E; Doyle RT; Jiang JG; Landau CJ; de Padova A
    Clin Ther; 2000 Jul; 22(7):879-92. PubMed ID: 10945514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
    Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
    Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.
    Naliboff BD; Wu SM; Schieffer B; Bolus R; Pham Q; Baria A; Aragaki D; Van Vort W; Davis F; Shekelle P
    J Pain; 2011 Feb; 12(2):288-96. PubMed ID: 21111684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of opioid analgesics for nontraumatic dental conditions in emergency departments.
    Okunseri C; Dionne RA; Gordon SM; Okunseri E; Szabo A
    Drug Alcohol Depend; 2015 Nov; 156():261-266. PubMed ID: 26471416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
    Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
    Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
    Zacny JP; Gutierrez S
    Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
    Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
    JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
    Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
    J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative safety of opioids for nonmalignant pain in older adults.
    Solomon DH; Rassen JA; Glynn RJ; Garneau K; Levin R; Lee J; Schneeweiss S
    Arch Intern Med; 2010 Dec; 170(22):1979-86. PubMed ID: 21149754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.